Presently, MAO-A inhibitors play an important role in the control of neurological disorders, anxiety, and depression, while MAO-B inhibitors could potentially be used as therapeutic agents for Parkinson’s and Alzheimer’s diseases [13]. The gene discussed is MAOA; the disease is depressive disorder.